{"paper_id":"6be790e1-0606-4382-8433-049b7895ce15","body_text":"Abstract\nMiscarriage occurs in between 10% and 30% of all spontaneous pregnancies (Shoham et al. 1991). Infertility is also common, affecting about 30% of couples (Hull et al. 1985). The causes of infertility are multiple and diverse, yet some, for example endometriosis and the polycystic ovary syndrome, may also affect successful implantation and pregnancy outcome. With the development of the techniques of assisted conception it is now possible either to overcome or to circumvent the majority of problems presented by the subfertile couple. One of the main questions to have arisen from the various therapies available is: Do they increase the rate of miscarriage or fetal malformations? And if they are found to do so, is this secondary to the treatment or a reflection of the underlying fertility disorder?\nPreview\nUnable to display preview. Download preview PDF.\nSimilar content being viewed by others\nReferences\nAbdalla HI, Ahuja KK, Leonard T, Morris NN, Honour JW, Jacobs HS (1990) Comparative trial of luteinising hormone releasing hormone analogue/HMG and clomiphene citrate/HMG in an assisted conception programme. Fertil Steril 53:473–478\nAbdulwahid NA, Adams J, Van der Spuy ZM, Jacobs HS (1985) Gonadotrophin control of follicular development. Clin Endocrinol 23:613–626\nAdashi EY, Rock JA, Sapp KC, Martin EJ, Wentz AC, Jones GS (1979) Gestational outcome of clomiphene-related conceptions. Fertil Steril 31:620–626\nAhlgren M, Kallen B, Rannevik G (1976) Outcome of pregnancy after clomiphene therapy. Acta Obstet Gynecol Scand 55:371–375\nAndrews MC, Muasher SJ, Levy D, Jones HW, Garcia JE, Rosenwaks Z, Jones GS, Acosta AA (1986) An analysis of the obstetric outcome of 125 consecutive pregnancies conceived in vitro and resulting in 100 deliveries. Am J Obstet Gynecol 154:848–854\nAustralian IVF Collaborative Group (1985) High incidence of preterm births and early losses in pregnancy after IVF. Br Med J 291:1160–1163\nBaird PA, Sadovnick AD, Yee IML (1991) Maternal age and birth defects: a population study. Lancet 337:527–530\nBen-Rafael Z, Dor J, Mashiach S, Blankstein J, Lunenfeld B, Serr DM (1983) Abortion rate in pregnancies following ovulation induced by human menopausal gonadotropin/human chorionic gonadotropin. Fertil Steril 39:157\nBerman P (1975) Congenital abnormalities associated with maternal clomiphene ingestion. Lancet i:878\nBishop PMF (1970) Clomiphene. Br Med Bull 26:22–25\nBohrer M, Kemmann E (1987) Risk factors for spontaneous abortion in menotropin-treated women. Fertil Steril 48:571\nBoue JG, Boue A (1973) Increased frequency of chromosomal anomalies in abortions after induced ovulation. Lancet i:679\nBoue A, Boue J (1977) Le role des anomalies chromosomiques dans les echecs de la reproduction. J Gynecol Obstet Biol Reprod 6:5–21\nBrambati B (1990) Fate of human pregnancies. In: Edwards RG (ed): Establishing a successful human pregnancy, Serono Symposia, vol. 66. Raven Press, NY, pp 269–281\nBrown GB (1986) Gonadotropins. In: Insler V, Lunenfeld B (eds) Infertility: male and female. Churchill Livingstone, New York, pp 359–373\nBuvat J, Marcolin G, Guittard C, Herbaut JC, Louvet AL, Dehaone JL (1990) Luteal support after LHRH agonist for IVF: superiority of human chorioinic gonadotropin over oral progesterone. Fertil Steril 53:490–494\nCaspi E, Ronen J, Schreyer P, Goldberg MD (1976) The outcome of pregnancy after gonadotropin therapy. Br J Obstet Gynaecol 83:967–971\nCohen J, Mayaux MJ, Guihard-Moscato ML (1988) Pregnancy outcomes after in vitro fertilization: A collaborative study on 2342 pregnancies. Ann NY Acad Sci 541:1–6\nConway GS, Honour JW, Jacobs HS (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 30:459–470\nCornel MC, Kate LPT, Dukes MN, de Jong VD, Berg LTW, Meyboom RHB, Garbis H, Peters PW (1989) Ovulation induction and neural tube defects. Lancet i:1386\nCorsan GH, Kemmann E (1990) Risk of a second consecutive first-trimester spontaneous abortion in women who conceive with menotropins. Fertil Steril 53:817–821\nCorson SL, Dickey RP, Gocial B, Batzer FR, Eisenberg E, Huppert L, Maislin G (1989) Outcome in 242 in vitro fertilization-embryo replacement or gamete intrafallopian transfer-induced pregnancies. Fertil Steril 51:644–650\nCzeizel A (1989) Ovulation induction and neural tube defects. Lancet i:167\nDekel N, Galiani D, Aberdam E (1990) Regulation of rat oocyte maturation: involvement of protein kinases. In: Bavister BD, Cummins J, Roldan ERS (eds) Fertilisation in mammals. Serono Symposia, Norwell, USA, pp 17–24\nDowns SM (1990) Maintenance of meiotic arrest in mammalian oocytes. In: Bavister BD, Cummins & Roldan ERS (eds) Fertilisation in mammals, pp 5–16. Serono Symposia, Norwell, USA\nDyson JL, Kohler HG (1973) Anencephaly and ovulation stimulation. Lancet i: 1256–1257\nEdmonds DK, Lindsay KS, Miller JF, Williamson E, Wood PJ (1982) Early embryonic mortality in women. Fertil Steril 38:447–453\nErickson GF, Magoffin DA, Dyer CA, Hofeditz C (1985) The ovarian androgen producing cells: a review of structure/function relationships. Endo Rev 6:371–399\nField B, Kerr C (1974) Ovulation stimulation and defects of neural-tube closure. Lancet ii:1511\nFleming R, Haxton MJ, Hamilton MPR, McCune GS, Black WP, Macnaughton MC, Coutts JRT (1985) Successful treatment of infertile women with oligomenorrhoea using a combination of a luteinising hormone releasing hormone agonist and exogenous gonadotrophin. Br J Obstet Gynaecol 92:369–374\nFleming R, Jamieson ME, Hamilton MPR, Black WP, Macnaughton MC, Coutts JRT (1988) The use of gonadotrophin releasing hormone analogues in combination with exogenous gonadotropins in infertile women. Acta Endocrinol, suppl 288, 119:77–84\nFleming R, Coutts JRT (1988) luteinising hormone releasing hormone analogues for ovulation induction, with particular reference to polycystic ovary syndrome. In: Healy D (ed) Anti- Hormones in Clinical Gynaecology, Bailliere’s Clin Obstet Gynaecol 2:677–688\nFowler PA, Messinis IE, Templeton AA (1989) Gonadotrophin surge-attenuating factor activity in human follicular fluid is different from inhibin. J Repro Fert, Abs series 4 no. 17\nFrydman R, Belaisch-Allart JC, Fries N, Hazout A, Glissant A, Testart J (1986) An obstetric assessment of the first 100 births from the in vitro fertilization program at Clamont, France. Am J Obstet Gynecol 154:550–555\nFrydman R, Fries N, Testart J et al. (1988) Luteinising hormone releasing hormone agonists in in- vitro fertilisation: different methods of utilization and comparison with previous ovulation stimulation treatments. Hum Reprod 3:559–561\nFuruhjelm M, Jonson B, Lagergren CC (1962) The quality of human semen in spontaneous abortion. Int J Fertil 7:17–21\nGarcia J, Jones GS, Wentz AC (1977) The use of clomiphene citrate. Fertil Steril 28:707–717\nGemzell CA (1967) Clomiphene induction of ovulation. In: Westlin B, Wiqvist N (eds). Fertility and sterility. Excerpta Medica Foundation, Amsterdam, p 43\nGoldfarb AF, Morales A, Rakoff AE, Protos P (1968) Critical review of 160 clomiphene related pregnancies. Obstet Gynecol 31:342–345\nGreenblatt RB, Barfield WE, Jungck EC, Ray AW (1961) Induction of ovulation with MRL-41. JAMA 178:101\nGreenblatt RB, Roy S, Mahesh VB, Barfield W, Jungck EC (1962) Induction of ovulation. Am J Obstet Gynecol 84:900–907\nHack M, Brish M, Serr DM, Insler V, Lunenfeld B (1970) Outcome of pregnancy after induced ovulation. Follow-up of pregnancies and children born after gonadotropin therapy. JAMA 211:791–976\nHack M, Brish M, Serr DM, Insler V, Salomy M, Lunenfeld B (1972) Outcome of pregnancy after induced ovulation. JAMA 220:1329–1333\nHarlap S (1976) Ovulation induction and congenital malformations. Lancet ii:961\nHassold T, Jacobs P, Kline J, Stein Z, Warburton D (1980) Effect of maternal age on autosomal trisomies. Ann Hum Genet 44:29–36\nHertig AT (1967) The overall problem in man. In Benirschke K (ed) Comparative aspects of reproductive failure. Springer-Verlag, NY, pp 11–41\nHomburg R, Armar NA, Eshel A, Adams J, Jacobs HS (1988) Influence of serum luteinising hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br Med J 297:1024–1026\nHomburg R, Eshel A, Armar NA, Tucker M, Mason PW, Adams J, Kilborn J, Sutherland IA, Jacobs HS (1989) One hundred pregnancies after treatment with pulsatile luteinising hormone releasing hormone to induce ovulation. Br Med J 298:809–812\nHomburg R, Eshel A, Kilborn J, Adams J, Jacobs HS (1990) Combined luteinising hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries. Hum Repro 5:32–35\nHook EB, Woodbury DF, Albright SG (1979) Rates of trisomy 18 in livebirths, stillbirths and at amniocentesis. Birth defects: original article series. New York: A. R. Liss, 15(5c):81–89\nHowies CM, Macnamee MC, Edwards RG, Goswamy R, Steptoe PC (1986) Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation. Lancet i:521—522\nHull MGR (1990) Indications for assisted conception. In: Edwards RG (ed) Assisted Human Conception. Br Med Bull 46:580–595\nHull MGR, Glazener CM A, Kelly NJ et al. (1985) Population study of causes, treatment and outcome of infertility. Br Med J 291:1693–1697\nJacobs HS, Porter R, Eshel A, Craft I (1987) Profertility uses of luteinising hormone releasing hormone agonist analogues. In: Vickery BH, Nestor J J (eds) LHRH and its Analogs. MTP Press Ltd, Lancaster, pp 303–322\nJames WH (1974) Anencephaly, ovulation stimulation and subfertility. Lancet ii: 1353\nJoel CA (1966) New etiologic aspects of habitual abortion and infertility with special reference to the male factor. Fertil Steril 17:374–379\nJohnson P, Pearch JM (1990) Recurrent spontaneous abortion and polycystic ovarian disease: comparison of two regimens to induce ovulation. Br Med J 301:154–156\nJones GS, Acosta AA, Garcia JE, Bernadus RE, Rosenwaks Z (1985) The effect of follicle stimulating hormone without additional luteinising hormone on follicular stimulation and oocyte development in normal ovulatory women. Fertil Steril 43:696–702\nKarow WG, Payne SA (1968) Pregnancy after clomiphene citrate treatment. Fertil Steril 19:351–362\nKnight PG, Lacey M, Peter JLT, Whitehead SA (1990) Demonstration of a non-steroidal factor in human follicular fluid that attenuates the self-priming action of gonadotrophin-releasing hormone on pituitary gonadotropes. Biol Repro 42:613–618\nKurachi K, Aono T, Minagawa J, Miyake A (1983) Congenital malformations of newborn infants after clomiphene-induced ovulation. Fertil Steril 40:187–189\nLam S-Y, Baker HWG, Evans JH, Pepperell RJ (1989) Factors affecting fetal loss in induction of ovulation with gonadotrophins: increased abortion rates related to hormonal patterns in conceptual cycles. Am J Obstet Gynecol 160:621–629\nLeeton J, Trounson A, Jessup D (1985) Support of the luteal phase in in vitro fertilization programs: result of a controlled trial with intramuscular Proluton. J In Vitro Fert Embryo Transfer 2:166–171\nLev-Gur M, Rodriguez LJ, Smith KD, Steinberger E (1990) Risk factors for pregnancy loss apparent at conception in infertile couples. Int J Fert 35:51–57\nLunenfeld B, Serr DM, Mashiach S et al. (1981) Therapy with gonadotropins: Where are we today? Analysis of 2890 menotropin treatment cycles in 914 patients. In: Insler V, Bettendorf G (eds) Advances in diagnosis and treatment of infertility. Elsevier Inc, Amsterdam, pp 27–31\nLunenfeld B, Blankstein J, Kotev-Emet S, Kokia E, Geier A (1986) Drugs used in ovulation induction: safety of patients and offspring. Hum Reprod 1:435–439\nMacDougall J, Tan SL, Jacobs HS (1992) Ovarian Hyperstimulation Syndrome after in-vitro fertilisation. Fertil Steril (in press)\nMacGregor AH, Johnson JE, Bunde CA (1968) Further clinical experience with clomiphene citrate. Fertil Steril 19:616–622\nMahadevan MM, Leader A, Taylor PJ (1985) Effects of low dose human chorionic gonadotrophin on corpus luteum function after embryo transfer. J In Vitro Fert Embryo Transfer 2:190–194\nMason P, Adams J, Morris DV, Tucker M, Price J, Voulgaris Z, Van der Spuy ZM, Sutherland I, Chambers GR, White S, Wheeler MJ, Jacobs HS (1984) Induction of ovulation with pulsatile luteinising hormone releasing hormone. Br Med J 288:181–185\nMedical Research International (1989) In vitro fertilization/embryo transfer in the United States: 1987 results from the National IVF-ET Registry. Fertil Steril 51:13–15\nMills JL, Simpson JL, Rhoads GG et al. (1990) Risk of neural tube defects in relation to maternal fertility and fertility drug use. Lancet 336:103–104\nMiyake A, Kurachi H, Wakimoto H, Hirota K, Terakawa N, Aono T, Tanizawa O (1988) Second pregnancy with spontaneous ovulation following clomiphene- or gonadotropin-induced pregnancy. Eur J Obstet Gynecol Reprod Biol 27:1–5\nNational Perinatal Statistics Unit (NPSU) and the Fertility Society of Australia and New Zealand (1988) I VF and GIFT Pregnancies Australia and New Zealand, 1987. NPSU, 1988\nOlson JL, Rebar RW, Schreiber JR, Vaitukaitis JL (1983) Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin. Fertil Steril 39:284–289\nPenrose LS (1933) The relative effects of maternal and paternal age in mongolism. J Genet 27:219- 224\nPoland BJ, Miller JR, Jones DC, Trimble BK (1977) Reproductive counselling in patients who have had a spontaneous abortion. Am J Obstet Gynecol 127:685–691\nPoison DW, Mason HD, Saldahna MB, Franks S (1987) Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin Endocrinol 26:205–212\nPorter RN, Smith W, Craft IL, Abdulwahid NA, Jacobs HS (1984) Induction of ovulation for in-vitro fertilisation using buserelin and gonadotrophins. Lancet ii: 1284–1285\nRegan L, Braude PR, Trembath PL (1989) Influence of past reproductive performance on risk of spontaneous abortion. Br Med J 299:541–545\nRegan L, Owen EJ, Jacobs HS (1990) Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet ii: 1141–1144\nRomeu A, Muasher SJ, Acosta AA, Veeck LL, Diaz J, Jones GS, Jones HW, Rosenwaks Z (1987) Results of in vitro fertilization attempts in women 40 years of age and older: the Norfolk experience. Fertil Steril 47:130–136\nRutherford AJ, Subak-Sharpe RJ, Dawson MJ, Margara RA, Franks S, Winston RML (1988) Improvement of in-vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone. Br Med J 296:1765–1768\nSagle M, Bishop K, Alexander FM, Michel M, Bonney RC, Beard RW, Franks S (1988) Recurrent early miscarriage and polycystic ovaries. Br Med J 297:1027–1028\nSandler B (1973) Anencephaly and ovulation stimulation. Lancet ii:379\nSchwartz M, Jewelewicz R, Dyrenfurth I, Tropper P, Vande Wile RL (1980) The use of human menopausal and chorionic gonadotropins for ovulation induction. Am J Obstet Gynecol 138:801- 806\nSeppala M (1985) The World Collaborative Report on in vitro fertilization and embryo replacement: current state of the art in January 1984. Ann N Y Acad Sci 442:558–563\nSharma V, Riddle A, Mason BA, Pampiglione J, Campbell S (1988) An analysis of factors influencing the establishment of a clinical pregnancy in an ultrasound-based ambulatory in-vitro fertilisation program. Fertil Steril 49:468–478\nShoham Z, Borenstein R, Lunenfeld B, Pariente C (1990) Hormonal profiles following clomiphene citrate therapy in conception and nonconception cycles. Clin Endocrinol 33:271–278\nShoham Z, Zosmer A, Insler V (1991) Early miscarriage and fetal malformations after induction of ovulation (by clomiphene citrate and/or human menotropins), in vitro fertilization, and gamete intrafallopian transfer. Fertil Steril 55:1–11\nSingh M (1978) Possible relationship between clomiphene and neural tube defects. J Ped 93:152\nSmith KD, Rodriguez-Rigau LJ, Steinberger E (1981) The influence of ovulatory dysfunction and timing of insemination on the success of AID with fresh or cryopreserved semen. Fertil Steril 36:496–499\nSpadoni LR, Cox DW, Smith DC (1974) Use of human menopausal gonadotropin for the induction of ovulation. Am J Obstet Gynecol 120:988–992\nStanger JD, Yovich JL (1985) Reduced in-vitro fertilisation of human oocyte from patients with raised basal luteinising hormone levels during the follicular phase. Br J Obstet Gynaecol 92:385–393\nSteer C, Campbell S, Davies M, Mason B, Collins W (1989) Spontaneous abortion rates after natural and assisted conception. BMJ 299: 1317–1318\nSteinberger E, Rodriguez-Rigau LJ, Smith KD (1982) Interaction of the two partners in the couple. In Menchini Fabris GF, Pasini W, Martini L (eds) Therapy in Andrology. Int Cong Ser 596: 21–29\nTan SL, Riddle A, Sharma V, Mason B, Campbell S (1989) The relation between the number of gestation sacs seen after IVF-ET and outcome of pregnancy. Proceedings of the Xllth Asian and Oceanic Congress of Obstetrics and Gynaecology\nThomas A, Okamoto S, O’Shea F, Maclachlan V, Besanko M, Healy D (1989) Do raised serum luteinising hormone levels during stimulation for in-vitro fertilisation predict outcome? Br J Obstet Gynaecol 96:1328–1332\nToshinobu T, Seiichiro F, Noriaki S, Kihyoe I (1979) Correlation between dosage or duration of clomid therapy and abortion rate. Int J Fert 24:193–197\nTrimble BK, Baird PA (1978) Maternal age and Down syndrome. Age specific incidence rates by single year maternal age intervals. Am J Med Genet 1:1–5\nTrounson A, Wood C (1984) In vitro fertilisation results, 1972–1982, at Monash University, Queen Victoria, and Epworth Medical Centres. J IVF-ET 1:42–47\nTrounson A, Howlett D, Rogers P, Hoppen HO (1986) The effect of progesterone supplementation around the time of oocyte recovery in patients superovulated for in vitro fertilization. Fertil Steril 45:532–537\nWall JA, Franklin RR, Kaufman RH (1964) Reversal of benign and malignant endometrial changes with clomiphene. Am J Obstet Gynecol 88:1–7\nWang CF, Gemzell C (1980) The use of human gonadotrophins for the induction of ovulation in women with polycystic ovary syndrome. Clin Endocrinol 12: 479–486\nWatson H, Hamilton-Fairly D, Kiddy D, Bray C, Armstrong P, Beard R, Bonrey R, Franks S (1989) Abnormalities of follicular phase luteinising hormone secretion in women with recurrent early miscarriage. J Endocrinol 123 suppl, Abstract 25\nWeir WC, Hendricks CH (1969) The reproductive capacity of an infertile population. Fertil Steril 20:289–298\nYovich JL, Stanger JD, Yovich JM, Tuvik A (1984) Assessment and hormonal treatment of the luteal phase of IVF cycles. Aus N Z J Obstet Gynaecol 24:125\nYovich JL, McColm SC, Yovich JM, Matson PL (1985) Early luteal serum progesterone concentrations are higher in conception cycles. Fertil steril 44:185–191\nYovich JL, Matson PL (1988) Early pregnancy wastage after gamete manipulation. Br J Obstet Gynaecol 95:1120–1127\nYovich JL, Edirisinghe WR, Cummins JM (1991) Evaluation of luteal support therapy in a randomized controlled study within a gamete intrafallopian transfer program. Fertil Steril 55:131- 139\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 1992 Springer-Verlag London Limited\nAbout this chapter\nCite this chapter\nBalen, A.H., Yovich, J.L. (1992). Miscarriage Following Assisted Conception. In: Stabile, I., Grudzinskas, J.G., Chard, T. (eds) Spontaneous Abortion. Springer, London. https://doi.org/10.1007/978-1-4471-1918-0_9\nDownload citation\nDOI: https://doi.org/10.1007/978-1-4471-1918-0_9\nPublisher Name: Springer, London\nPrint ISBN: 978-1-4471-1920-3\nOnline ISBN: 978-1-4471-1918-0\neBook Packages: Springer Book Archive\nKeywords\nThese keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.","source_license":"CC0","license_restricted":false}